TGFB1 and cancer: In cancer, this inhibition could attenuate the TGFβ-dependent EMT; however, due to the pleiotropic functions of TGFβ signaling – which regulates many normal physiological functions and various steps of cancer progression – the effects of TGFβ inhibitors in cancer therapy remain unpredictable (63).